Publicaciones en las que colabora con F. Gutiérrez Nicolás (7)

2020

  1. Pharmacokinetics of Trastuzumab After Subcutaneous and Intravenous Administration in Obese Patients

    Annals of Pharmacotherapy, Vol. 54, Núm. 8, pp. 775-779

2018

  1. Effect of UGT, SLCO, ABCB and ABCC polymorphisms on irinotecan toxicity

    Medicina Clinica, Vol. 151, Núm. 11, pp. 425-430

2017

  1. 5-fluorouracil toxicity in the treatment of colon cancer associated with the genetic polymorphism 2846 A>G (rs67376798)

    Journal of Oncology Pharmacy Practice, Vol. 23, Núm. 5, pp. 396-398

  2. Influence of Anthropometric Characteristics in Patients With Her2-Positive Breast Cancer on Initial Plasma Concentrations of Trastuzumab

    Annals of Pharmacotherapy, Vol. 51, Núm. 11, pp. 976-980

2016

  1. Reducing the degree of colonisation of venous access catheters by continuous passive disinfection

    European Journal of Hospital Pharmacy , Vol. 23, Núm. 3, pp. 131-133

2015

  1. PP-025 Stability of intravitreal bevacizumab solution in polypropylene syringes in neovascular macular degeneration

    European Journal of Hospital Pharmacy, Vol. 22, Núm. Suppl 1

  2. Validation of a fast and low-cost alkaline lysis method for gDNA extraction in a pharmacogenetic context

    Cancer Chemotherapy and Pharmacology, Vol. 75, Núm. 5, pp. 1095-1098